Syndax Pharmaceuticals Inc (SNDX)
Operating Income Growth
42.73%
TTM · Period ending:
SNDX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported42.73%period ending
Latest reported42.73%period ending
SNDX TTM Operating Income YoY % (-267.50% → 42.73%)
Year-over-year change
High-resolution chart · PNG
SNDX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 42.7312% | |
| 35.0046% | |
| 19.6036% | |
| 4.4553% | |
| -17.7305% | |
| -30.5418% | |
| -47.7137% | |
| -65.5041% | |
| -66.5963% | |
| -63.7233% | |
| -51.5281% | |
| -1,288.8722% | |
| -15,330.5727% | |
| -1,073.7549% | |
| -678.7796% | |
| 84.3672% | |
| 101.2723% | |
| 119.7937% | |
| 136.7109% | |
| -35.9156% | |
| -51.0396% | |
| -44.3695% | |
| -24.1297% | |
| -4.9484% | |
| 12.3146% | |
| 18.4786% | |
| 24.1671% | |
| 17.5781% | |
| 8.5256% | |
| -3.5139% | |
| -22.4715% | |
| -41.8349% | |
| -37.9022% | |
| -42.2038% | |
| -41.5574% | |
| -43.7004% | |
| -91.2262% | |
| -94.0641% | |
| -113.3574% | |
| -95.074% | |
| -32.9651% | |
| -13.9972% | |
| 3.8393% | |
| 8.5986% | |
| -35.7531% | |
| -93.7472% | |
| -148.8858% | |
| -267.503% |